Alkermes Trims Staff By 23% After Risperdal Consta Delay Aug. 27, 2002 By Aaron Lorenzo The fallout continues at Alkermes Inc., which following a series of recent setbacks reported a 23 percent reduction in its work force. (BioWorld Today)Read More
